Search

Terms/Glossary


News & Events > 2011 Press releases
Skriv ut

2011 Press releases


Displaying 1 - 10 of 25 articles





12 December 2011
Promising interim results of Phase II trial with elacytarabine in combination with idarubicin in patients with early stage acute myeloid leukaemia (AML) presented at ASH annual meeting
Clavis Pharma ASA (OSE: CLAVIS) announces that promising interim efficacy data from its Phase II clinical trial with elacytarabine in combination with idarubicin in patients with early stage acute myeloid leukaemia (AML) who have failed cytarabine-containing first-course chemotherapy were presented* on Saturday 10 December at the American Society of Haematology annual meeting (San Diego, CA, USA).

28 October 2011
Clavis Pharma’s Financial Calendar 2012


27 October 2011
Clavis Pharma Third Quarter 2011


24 October 2011
Clavis Pharma announces the completion of Study 002 Low hENT1 cut-off level determined for pivotal LEAP study of CP-4126 in patients with pancreatic cancer


20 October 2011
Invitation to presentation and webcast of Clavis Pharma's third quarter results 2011


27 September 2011
Clavis Pharma to present at Jefferies 2011 Global Healthcare Conference in London, UK.


25 August 2011
Clavis Pharma Second Quarter and First Half Report 2011


25 August 2011
Clavis Pharma expands Phase III CLAVELA study in patients with acute myeloid leukaemia (AML)


19 August 2011
Invitation to presentation of Clavis Pharma's second quarter results 2011


17 August 2011
Clavis Pharma announces encouraging interim results of Phase II trial with elacytarabine in combination with idarubicin in patients with early stage acute myeloid lymphoma (AML)